GOLGA6L10 Activators are a diverse array of chemical compounds that serve to enhance the functional activity of GOLGA6L10 through various biochemical mechanisms and signaling pathways. Compounds such as Forskolin and 8-Bromo-cAMP increase intracellular cAMP levels, thereby activating PKA which could potentially phosphorylate GOLGA6L10 or associated proteins, leading to enhanced activity of GOLGA6L10. Additionally, PMA, through the activation of PKC, and Epigallocatechin gallate (EGCG), by inhibiting competitive kinases, may result in the phosphorylation or altered interaction of GOLGA6L10, facilitating its role in the Golgi apparatus. In a similar vein, agents like Ionomycin and A23187 (Calcimycin) increase intracellular calcium, which might activate calcium-dependent signaling pathways that enhance GOLGA6L10 function. Furthermore, Okadaic Acid, by inhibiting protein phosphatases, could elevate the phosphorylation state of GOLGA6L10, thereby augmenting its activity.
In the context of cellular metabolism and trafficking, the activity of GOLGA6L10 can be influenced by chemicals that modulate these processes. Insulin, through the activation of the PI3K/Akt pathway, may indirectly enhance GOLGA6L10 function by modulating membrane dynamics and trafficking. Brefeldin A, by disrupting Golgi structure, and compounds like Oleic Acid, through their effects on lipid metabolism, could enhance the localization and interaction of GOLGA6L10 with other Golgi proteins, thus promoting its functional activity. Ionophores such as Monensin and Nigericin alter ion gradients and cellular pH, which could lead to the optimizationof GOLGA6L10's role in maintaining Golgi structure and function. These activators, by modulating the intracellular environment and the phosphorylation status of proteins, provide a multitiered approach to enhancing the activity of GOLGA6L10.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates PKA, which can phosphorylate various targets possibly including GOLGA6L10, enhancing its protein function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in multiple signaling pathways. PKC can phosphorylate GOLGA6L10 or its interacting proteins, enhancing its function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that might affect kinases which interact with or phosphorylate GOLGA6L10, thus reducing competition and potentially enhancing GOLGA6L10's function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent proteins and pathways that may enhance GOLGA6L10 activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA and could enhance GOLGA6L10's function through phosphorylation or interaction with PKA-regulated pathways. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which may indirectly enhance the function of GOLGA6L10 through downstream effects on trafficking and membrane dynamics. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins that could include GOLGA6L10, thus enhancing its function. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi structure and function, which may indirectly enhance GOLGA6L10 activity by affecting its localization and interaction with other Golgi proteins. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic Acid is known to affect lipid metabolism and membrane fluidity, which could enhance the function of GOLGA6L10 by affecting its membrane association in the Golgi apparatus. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, similar to Ionomycin, potentially enhancing GOLGA6L10 function via calcium-dependent signaling pathways. | ||||||